Bronchoectatic disease: the state of art and the clinical case.
DOI:
https://doi.org/10.26641/2307-0404.2018.3(part1).142360Keywords:
bronchoectatic disease, bronchiectasis, computed tomography, Pseudomonas aeruginosaAbstract
In connection with the increased diagnostic capabilities of X-ray methods, bronchiectasis is increasingly being diagnosed today. The main problem of patients’ management is the heterogeneity of the etiological factors, as well as the lack of evidence base for the effectiveness of therapy. The article presents a clinical case of bronchiectasis in a patient with chronic carriage of Pseudomonas aeruginosa (mucoid strain) and Klebsiella pneumoniae.
References
Pertseva TA, Kireyeva TV, Krykhtina MA. [Current view on pharmacotherapy of low respiratory tract infections: the place for macrolides]. Ukrayinskyi pulmonologichnyi zhurnal. 2015;3:49-55. Ukrainian.
Samsonova MV. [Bronchiectasis: a modern view of the problem]. Prakticheskaya pulmonologiya. 2017;1:75-76. Russian.
Feshchenko YuI, Dzyublik AYa. [Rational antibiotic therapy of patients with infections of lower respiratory ways]. Ukrayinskyi pulmonologichnyi zhurnal. 2009;4:5-8. Russian.
Aliberti S, Lonni S, Dore S et al. Clinical phenotypes in adult patients with bronchiectasis. Eur Respir J. 2016 Apr;47(4):1113-22. http://dx.doi.org/10.1183/13993003.01899-2015
Miguel Angel, Martínez-García MD, Juan-Jose Soler-Cataluña MD et al. Factors Associated With Lung Function Decline in Adult Patients With Stable Non-Cystic Fibrosis Bronchiectasis. Chest. 2007Nov;132(5):1565-72.
Barker AF. Bronchiectasis. N. Engl. J. Med. 2002;346(18):1383-93. http://dx.doi.org/10.1056/NEJMra012519
Luce Cantin, Alexander A Bankier, and Ronald L. Eisenberg. Bronchiectasis. American Journal of Roentgenology. 2009;193:158-71.
Chang AB, Grimwood K, Mulholland EK et al. Bronchiectasis in Indigenous children in remote Australian communities. Med J. Aust. 2002;177:200-4.
McDonnell MJ, Aliberti S, Goeminne PC et al. Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts. Thorax. 2016;71:1110-8. http://dx.doi.org/10.1136/thoraxjnl-2016-208481
Lonni S, Chalmers JD, Goeminne PC, McDonnell MJ, Dimakou K, De Soyza A, Polverino E, Van de Kerkhove C, Rutherford R, Davison J et al. Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity. Ann Am Thorac Soc. 2015;12(12):1764-70. http://dx.doi.org/10.1513/AnnalsATS.201507-472OC
Finch S, McDonnell MJ, Abo-Leyah H et al. A comprehensive analysis of the impact of Pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis. Ann Am Thorac Soc. 2015;12:1602-11.
Finklea JD, Khan G, Thomas S et al. Predictors of mortality in hospitalized patients with acute exacerbation of bronchiectasis. Respir Med. 2010;104:816-21. http://dx.doi.org/10.1016/j.rmed.2009.11.021
Kwak HJ, Moon J-YY, Choi YW et al. High prevalence of bronchiectasis in adults: analysis of CT findings in a health screening program. Tohoku J Exp Med. 2010;222:237-42. http://dx.doi.org/10.1620/tjem.222.237
Loebinger MR, Wells AU, Hansell DM et al. Mortality in bronchiectasis: a long-term study assessing the factors influencing survival. Eur Respir J. 2009;34:843-9. http://dx.doi.org/10.1183/09031936.00003709
Kyreeva T, Dmytrychenko V, Pertseva T, Bogatska K. Microbial landscape of sputum in patients with non-cystic fibrosis bronchiectasis. 2nd World Bronchiectasis Conference. 2017;52.
Mirsaeidi M, Hadid W, Ericsoussi B et al. Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis. International Journal of Infectious Diseases. 2013;17:1000-4. http://dx.doi.org/10.1016/j.ijid.2013.03.018.
Moulton BC, Barker AF. Pathogenesis of bronchiectasis. Clin Chest Med. 2012;33(2):211-7. http://dx.doi.org/10.1016/j.ccm.2012.02.004
Orriols R, Hernando R, Ferrer A et al. Eradication therapy against Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis. Respiration. 2015;90:299-305. http://dx.doi.org/10.1159/000438490
Polverino E, Goeminne PC, McDonnell MJ et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017;50. http://dx.doi.org/10.1183/13993003.00629-2017
Quint JK, Millett ER, Joshi M et al. Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: A population-based cohort study. Eur Respir J. 2016;47:186-193. http://dx.doi.org/10.1183/13993003.01033-2015
Rademacher J, Welte T. Bronchiectasis – diagnosis and treatment. Deutsches Aerzteblatt Online. 2011;108:809-15.
Raghu G, King TE, Behr J et al. Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1). Eur Respir J. 2010;35:118-23. http://dx.doi.org/10.1183/09031936.00188108.
Ringshausen FC, de Roux A, Pletz MW et al. Bronchiectasis-associated hospitalizations in Germany, 2005-2011: a population-based study of disease burden and trends. PLoS One. 2013;8:e71109. http://dx.doi.org/10.1371/journal.pone.0071109
Seitz AE, Olivier KN, Steiner CA et al. Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006. Chest. 2010;138:944-9. http://dx.doi.org/10.1378/chest.10-0099
Pamela J McShane, Edward T Naureckas, Gregory Tino et al. Non–Cystic Fibrosis Bronchiectasis. AJRCCM. 2013 Sept;188:6.
Yu-xing Jin, Yi Zhang, Liang Duan, Yang Yang, Ge-ning Jiang, Jia-an Ding. Surgical treatment of bronchiectasis: A retrospective observational study of 260 patients. International Journal of Surgery. 2014;12(10):1050-4. http://dx.doi.org/10.1016/j.ijsu.2014.08.398
Tashkin DP, Celli B, Senn S et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359:1543-54. http://dx.doi.org/10.1056/NEJMoa0805800
Thurlbeck WM. Chronic airflow obstruction. Thurlbeck pathology of the lung 2nd edition. 1995;804-8.
Weycker D, Edelsberg J, Oster G et al. Prevalence and economic burden of bronchiectasis. Clin Pulm Med. 2005;12:205-9. http://dx.doi.org/10.1097/01.cpm.0000171422.98696.ed.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2018 Medicni perspektivi (Medical perspectives)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.
